BG101011A - Formulation of the treatment of hiv/aids - Google Patents

Formulation of the treatment of hiv/aids

Info

Publication number
BG101011A
BG101011A BG101011A BG10101196A BG101011A BG 101011 A BG101011 A BG 101011A BG 101011 A BG101011 A BG 101011A BG 10101196 A BG10101196 A BG 10101196A BG 101011 A BG101011 A BG 101011A
Authority
BG
Bulgaria
Prior art keywords
formulation
treatment
hiv
aids
itsadministration
Prior art date
Application number
BG101011A
Other languages
Bulgarian (bg)
Inventor
Евгени Гъбев
Original Assignee
Анрет Оод
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анрет Оод filed Critical Анрет Оод
Priority to BG101011A priority Critical patent/BG101011A/en
Priority to PCT/BG1997/000013 priority patent/WO1998023276A2/en
Priority to AU49370/97A priority patent/AU4937097A/en
Publication of BG101011A publication Critical patent/BG101011A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a formulation manifesting increasedanti-HIV activity, practically being not toxic and having depoteffect. It is possible to rarify the intervals of itsadministration and reduce the doses which makes treatment cheaper.The formulation is a combination of azidotimidine and lithium ionsin wt. ratio from 30:1 to 20:1, incapsulated in liposomes.1 claim
BG101011A 1996-11-25 1996-11-25 Formulation of the treatment of hiv/aids BG101011A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BG101011A BG101011A (en) 1996-11-25 1996-11-25 Formulation of the treatment of hiv/aids
PCT/BG1997/000013 WO1998023276A2 (en) 1996-11-25 1997-11-14 Liposomes comprising azidothymidine and lithium for treating hiv/aids
AU49370/97A AU4937097A (en) 1996-11-25 1997-11-14 Liposomes comprising azidothymidine and lithium for treating hiv/aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG101011A BG101011A (en) 1996-11-25 1996-11-25 Formulation of the treatment of hiv/aids

Publications (1)

Publication Number Publication Date
BG101011A true BG101011A (en) 1998-05-29

Family

ID=3926767

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101011A BG101011A (en) 1996-11-25 1996-11-25 Formulation of the treatment of hiv/aids

Country Status (3)

Country Link
AU (1) AU4937097A (en)
BG (1) BG101011A (en)
WO (1) WO1998023276A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth

Also Published As

Publication number Publication date
AU4937097A (en) 1998-06-22
WO1998023276A3 (en) 1998-07-30
WO1998023276A2 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
EP0831873A4 (en) The treatment of hiv and other viral infections using combinatory therapy
TW370532B (en) The use of cetrorelix and other nona and decapeptides in the preparation of a medicament for combating AIDS and for growth stimulation
ZA9610139B (en) Treatment of the cns effects of hiv
MY119031A (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
ZA949219B (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread.
AU4443893A (en) Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
CA2235470A1 (en) Dentifrice compositions containing .beta.-phase calcium pyrophosphate, an anticalculus agent, and fluoride
IL108844A0 (en) Use of riluzole in the reatment of neuro-aids
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
OA09194A (en) "Insecticidal treatment and compositions therefor".
BG102636A (en) Nail growth stimulation preparations
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
EP0676963A4 (en) Hyaluronic acid-urea pharmaceutical compositions and uses.
BG102667A (en) Diosgenine-containing composition
ZA935086B (en) Skin regenerating cosmetic composition
BG101011A (en) Formulation of the treatment of hiv/aids
EP0612840A3 (en) Cyclic compounds and their use as perfuming ingredients.
EP0789565A4 (en) Prevention of hiv infection
BG104914A (en) Paroxetine maleate
EP0472078A3 (en) Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses
PL317876A1 (en) Combined treatment of hiv infections
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions
GR1002385B (en) Clean form of streptogramines, preparation and pharmaceutical compositions comprising it.
YU23498A (en) Herbicidal 3,5-difluoropiridines